Veracyte (VCYT) Operating Income (2016 - 2025)
Historic Operating Income for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $22.9 million.
- Veracyte's Operating Income rose 9094.62% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 20516.99%. This contributed to the annual value of $16.1 million for FY2024, which is 11881.46% up from last year.
- Latest data reveals that Veracyte reported Operating Income of $22.9 million as of Q3 2025, which was up 9094.62% from -$5.3 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Operating Income registered a high of $22.9 million during Q3 2025, and its lowest value of -$45.4 million during Q1 2021.
- In the last 5 years, Veracyte's Operating Income had a median value of -$8.1 million in 2023 and averaged -$9.1 million.
- In the last 5 years, Veracyte's Operating Income crashed by 55511.07% in 2023 and then surged by 16237.11% in 2025.
- Quarter analysis of 5 years shows Veracyte's Operating Income stood at -$12.3 million in 2021, then surged by 56.05% to -$5.4 million in 2022, then tumbled by 555.11% to -$35.5 million in 2023, then skyrocketed by 111.76% to $4.2 million in 2024, then soared by 449.6% to $22.9 million in 2025.
- Its Operating Income stands at $22.9 million for Q3 2025, versus -$5.3 million for Q2 2025 and $2.9 million for Q1 2025.